Role of the pathologist in active surveillance for prostate cancer

Roberta Mazzucchelli, Andrea B. Galosi, Matteo Santoni, Antonio Lopez-Beltran, Marina Scarpelli, Liang Cheng, Rodolfo Montironi

Research output: Contribution to journalArticle

4 Scopus citations


Active surveillance (AS) is an alternative strategy that aims to minimize overtreatment by selecting only patients with significant prostate cancer (PCa) tumors for immediate treatment. Patients with favorable tumor characteristics are closely monitored using serum prostatespecific antigen (PSA) levels and serial biopsies of the prostate. In addition, other predictors of tumor progression, such as PSA doubling time, can be used during AS management. AS represents an excellent opportunity to identify molecular biomarkers of PCa behavior and to develop novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)65-68
Number of pages4
JournalAnalytical and Quantitative Cytology and Histology
Issue number1
StatePublished - Jan 1 2015


  • Active surveillance
  • Immunohistochemistry
  • Prostate biopsy
  • Prostate cancer
  • Tumor extent

ASJC Scopus subject areas

  • Anatomy
  • Histology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Role of the pathologist in active surveillance for prostate cancer'. Together they form a unique fingerprint.

  • Cite this

    Mazzucchelli, R., Galosi, A. B., Santoni, M., Lopez-Beltran, A., Scarpelli, M., Cheng, L., & Montironi, R. (2015). Role of the pathologist in active surveillance for prostate cancer. Analytical and Quantitative Cytology and Histology, 37(1), 65-68.